Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MDRX 
Veradigm Inc. (MDRX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: MDRX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5.83
1 Year Target Price $5.83
| 1 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -10.69% | Avg. Invested days 51 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 517.27M USD | Price to earnings Ratio - | 1Y Target Price 5.83 |
Price to earnings Ratio - | 1Y Target Price 5.83 | ||
Volume (30-day avg) 3 | Beta 0.68 | 52 Weeks Range 3.00 - 11.80 | Updated Date 10/23/2025 |
52 Weeks Range 3.00 - 11.80 | Updated Date 10/23/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.7% | Operating Margin (TTM) 16.59% |
Management Effectiveness
Return on Assets (TTM) -0.62% | Return on Equity (TTM) -1.69% |
Valuation
Trailing PE - | Forward PE 15.17 | Enterprise Value 284680000 | Price to Sales(TTM) 0.88 |
Enterprise Value 284680000 | Price to Sales(TTM) 0.88 | ||
Enterprise Value to Revenue 0.48 | Enterprise Value to EBITDA 4.87 | Shares Outstanding 108900000 | Shares Floating 66488725 |
Shares Outstanding 108900000 | Shares Floating 66488725 | ||
Percent Insiders 4.26 | Percent Institutions 40.99 |
Upturn AI SWOT
Veradigm Inc.
Company Overview
History and Background
Veradigm Inc., formerly Allscripts Healthcare Solutions, was founded in 1986. It evolved through mergers and acquisitions to become a provider of healthcare information technology solutions. Significant milestones include strategic acquisitions to expand its product portfolio and its focus on data-driven insights.
Core Business Areas
- Provider Solutions: Offers electronic health records (EHR), practice management, and revenue cycle management solutions for healthcare providers.
- Payer Solutions: Provides data analytics and connectivity solutions to payers for risk management, quality improvement, and cost containment.
- Life Sciences Solutions: Delivers data and insights to pharmaceutical and life sciences companies to support drug development, commercialization, and real-world evidence generation.
- Veradigm Network: This network of providers, payers, and life sciences companies facilitates data exchange and collaboration.
Leadership and Structure
Veradigm is led by a Chief Executive Officer (CEO) and a senior management team. The organizational structure includes functional departments such as sales, marketing, product development, and finance.
Top Products and Market Share
Key Offerings
- Veradigm EHR: Electronic Health Record (EHR) system used by healthcare providers. Competitors: Epic Systems, Cerner, Meditech. Market share data is fragmented but Veradigm holds a significant position within the ambulatory EHR market.
- Veradigm Practice Management: Software for managing the administrative and financial aspects of medical practices. Competitors: Athenahealth, eClinicalWorks, NextGen Healthcare.
- Veradigm Payer Analytics: Data analytics solutions for healthcare payers, providing insights into risk, quality, and cost. Competitors: Optum, Cotiviti.
- Accrete Health: Accrete Health enhances financial outcomes for healthcare providers by leveraging patient-centric data intelligence at the point of care. Competitors: Experian Health, Change Healthcare.
Market Dynamics
Industry Overview
The healthcare IT industry is characterized by increasing adoption of digital health solutions, regulatory pressures to improve interoperability, and growing demand for data-driven insights to improve patient outcomes and reduce costs.
Positioning
Veradigm is positioned as a provider of integrated solutions across the healthcare ecosystem, with a focus on leveraging data and insights to improve care delivery and outcomes. Competitive advantages include its established network of providers, payers, and life sciences companies.
Total Addressable Market (TAM)
The total addressable market (TAM) for healthcare IT is expected to reach hundreds of billions of dollars in the coming years. Veradigm is positioned to capture a portion of this TAM through its comprehensive suite of solutions and its focus on data-driven insights.
Upturn SWOT Analysis
Strengths
- Established network of providers, payers, and life sciences companies
- Comprehensive suite of healthcare IT solutions
- Focus on data and analytics
- Strong brand recognition
- Experience with value based care.
Weaknesses
- Integration complexities due to acquisitions
- Competition from larger, more diversified players
- Dependence on regulatory changes
- Complex sales cycles within the healthcare industry.
- Debt burden after the sale of the hospitals and large facility business segment.
Opportunities
- Growing demand for digital health solutions
- Expansion into new markets and geographies
- Partnerships and collaborations with other healthcare organizations
- Increasing adoption of value-based care models.
- Ability to integrate AI into existing offerings.
Threats
- Increased competition from new entrants
- Regulatory changes impacting data privacy and security
- Cybersecurity threats
- Economic downturn impacting healthcare spending.
- Potential for technology obsolescence.
Competitors and Market Share
Key Competitors
- EPIC
- ATHN
- CERN
Competitive Landscape
Veradigm faces competition from larger, more diversified players like Epic and Cerner. Its advantages include a focus on data and analytics, but challenges remain in integrating acquisitions and keeping pace with technological advancements.
Major Acquisitions
PRIME Research
- Year: 2021
- Acquisition Price (USD millions): 65
- Strategic Rationale: To enhance its data analytics capabilities and expand its research offerings for life sciences companies.
Accrete Health Partners
- Year: 2022
- Acquisition Price (USD millions): 40
- Strategic Rationale: To enhance financial outcomes for healthcare providers by leveraging patient-centric data intelligence at the point of care.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been influenced by acquisitions, product development, and market expansion. The past growth rate has been in the single digits due to competitive pressure.
Future Projections: Future growth projections depend on factors such as market trends, competitive landscape, and strategic initiatives. Analyst estimates need to be checked from latest research reports.
Recent Initiatives: Recent initiatives include product enhancements, strategic partnerships, and market expansion efforts. Focus on expanding the payer and life sciences business to drive growth.
Summary
Veradigm is a player in the healthcare IT sector, offering a range of solutions. It boasts a strong network and a focus on data, but faces competition from larger firms. While its past performance indicates potential, Veradigm needs to execute its strategic initiatives to maintain its position and continue to grow amid increasing regulatory pressure.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Industry reports
- Analyst reports
- Third-party data providers
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market share data is approximate and based on available information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Veradigm Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 1999-07-26 | CEO - | ||
Sector Healthcare | Industry Health Information Services | Full time employees 2450 | Website https://veradigm.com |
Full time employees 2450 | Website https://veradigm.com | ||
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.